Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
dzif-10c (1 trial)
ipilimumab (yervoy) (1 trial)
nivolumab (opdivo) (1 trial)
sars-cov-2 specific t cells (1 trial)
Coronavirus Infections (Phase 2)
Severe Acute Respiratory Syndrome (Phase 2)
Trials (3 total)
Trial APIs (4 total)